Angioplasty Balloons Market: Global Industry Analysis and Forecast (2024-2030)

  • Angioplasty Balloons Market size was valued at USD 2.72 Bn. in 2023 and the Angioplasty Balloons revenue is expected to grow at a CAGR of 3.7% from 2024 to 2030, reaching nearly USD 3.51 Bn. by 2030.

  • Format : PDF | Report ID : SMR_2059

Angioplasty Balloons Market Overview:

Angioplasty balloons are medical devices utilized in surgical processes that are incorporated in the process of dilating and unblocking blood arteries that have been clogged up. Drug-eluting, normal, scoring, and cutting angioplasty balloons are some of the common types of angioplasty balloon designs. The growth of Angioplasty Balloons market is expected because angioplasty balloons are more effective than other conventional angioplasty treatments. In addition, there is a growing incidence of heart problems that evoke targeted, highly effective treatment options.

 

A greater number of angioplasty operations are carried out as a result of improvements in diagnostic methods and instruments for cardiovascular disorders that enable earlier identification and treatment. The market for angioplasty balloons is propelled by rising awareness of cardiovascular illnesses and the implementation of screening programmes that result in early diagnosis and intervention. Moreover, the demand for angioplasty catheters is expected to rise because of an aging population with diabetes and heart disease. Furthermore, the growing inclination towards minimally invasive procedures is anticipated to propel the market growth, since these procedures entail the use of angioplasty balloons and tiny incisions to identify and address the impacted blood arteries.

Angioplasty Balloons Market

 

To get more Insights: Request Free Sample Report

 

Angioplasty Balloons Market Dynamics:

Rising Incidences of Cardiovascular Diseases Propelling the Growth of the Market.

The need for angioplasty treatments is increased by the rising prevalence of cardiovascular diseases (CVDs), such as peripheral artery disease and coronary artery disease. This in turn propels the market for angioplasty balloons. Advances in angioplasty balloon technology, like the creation of cutting and drug-eluting balloons, increase treatment efficacy and broaden the Angioplasty Balloons Market. The need for angioplasty operations and related devices rises as the world's population ages and age-related cardiovascular problems become more common.

 

The market for angioplasty balloons is growing as a result of patient’s preference for less invasive procedures over traditional surgical techniques since they have shorter recovery periods, need fewer hospital stays, and have fewer complications. Favourable reimbursement regulations in several regions lead patients into opting for angioplasty procedures. Wider range of patients are able to afford angioplasty now hence use of financial support for market growth driving the growth of the Angioplasty Balloons Market.

 

High Costs of the Procedures and Devices Affect the Growth of the Market.

The high expense of angioplasty treatments and sophisticated balloons used in angioplasty, including drug-eluting balloons, a major obstacle, particularly in low and middle income nations where funds for healthcare are less. The lengthy and stringent regulatory approval procedures for medical equipment, such as angioplasty balloons, cause delays in the release of new goods onto the market. Even though angioplasty procedures are less invasive, they still result in consequences including restenosis (re-narrowing of the artery), which restrict their use and require further treatments.

 

Unfair access to medical treatment, especially in remote or underprivileged places, prevent improved angioplasty balloons from being widely used. Barriers based on geography and socioeconomic status are important to consider for the growth of the market.  The demand for angioplasty balloons is impacted by the availability of substitute therapies for cardiovascular disorders, such as coronary artery bypass grafting (CABG), as well as more recent methods like bioresorbable vascular scaffolds affecting the growth of the market.

 

Angioplasty Balloons Market Segment Analysis:

By Type, normal balloons, scoring balloons, drug-eluting balloons, and cutting balloons are the several categories under which the Angioplasty Balloons are classified. According to estimates, the normal balloon segment is anticipated to continue to dominate the industry during the forecasted period and currently holds the largest revenue share in the angioplasty balloons market. The use of normal balloons in angioplasty is made possible by their high burst pressure, which is the highest pressure the balloon withstand before rupturing, and affordability. The angioplasty balloons market sector is growing because of advantages including improved lesion targeting, reduced risk, and better patency. All these factors are driving the growth of the segment in the market.

Angioplasty Balloons Market1

Angioplasty Balloons Market Regional Insight:

North America held the highest market share in the Angioplasty Balloons Market. The market is primarily driven by the existence of major competitors, increasing healthcare spending, and an increase in percutaneous coronary interventions. The area is also a hub for new product inventions and technological advancements related to catheters and angioplasty balloons, which supports the growth of the angioplasty balloon industry. Cardiovascular disorders, such as peripheral artery disease (PAD) and coronary artery disease (CAD), are comparatively common in North America. This incidence is influenced by a number of factors, including aging populations, sedentary lifestyles, and poor dietary practices.

 

North America has some of the highest per capita healthcare spending in the world, modern medical techniques like angioplasty are used more frequently in the region. The region's high rates of obesity, diabetes, and other lifestyle-related illnesses lead to an increase in the prevalence of cardiovascular ailments, which makes the use of angioplasty balloons necessary. Angioplasty balloons are still in high demand in North America since angioplasty is a common first line of treatment for many cardiovascular diseases. All these factors are fuelling the growth of the Angioplasty Balloons Market in the region.

Angioplasty Balloons Market2

Angioplasty Balloons Market Competitive Landscape:

  • On January 2023, The FDA approved the Stellarex 0.035” OTW Drug-coated Angioplasty Balloon from Philips Image Guided Therapy Corp. The FDA has expanded the indications for use to include re-opening blood vessels within a previously placed stent. The balloon is coated with paclitaxel, which may prevent arteries from narrowing again.
  • In September 2022, Advanced NanoTherapies, Inc. reported the U.S. FDA granted the company a Breakthrough Device designation for its SirPlux Duo Drug-Coated Balloon (DCB) for coronary artery disease in vessels less than 3.0mm.
  • In October 2022, MedAlliance's novel sirolimus-eluting balloon, SELUTION SLR received FDA Investigational Device Exemption (IDE) approval to initiate its coronary pivotal clinical trial.

 

Angioplasty Balloons Market Scope:

Angioplasty Balloons Market

Market Size in 2023

USD 2.72 Bn.

Market Size in 2030

USD 3.51 Bn.

CAGR (2024-2030)

3.7 %

Historic Data

2018-2022

Base Year

2023

Forecast Period

2024-2030

   Segments

By Type

Normal Balloons

Scoring Balloons

Drug-eluting balloons

Cutting balloon

By Application

 Peripheral

 Coronary

By End Use

Hospitals  

Ambulatory Surgical Centres

Other End Users

Regional Scope

North America- United States, Canada, and Mexico

Europe – UK, France, Germany, Italy, Spain, Sweden, Russia, and Rest of Europe

Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC

Middle East and Africa - South Africa, GCC, Egypt, Rest of the Middle East and Africa

South America – Brazil, Argentina, Rest of South America

 

Angioplasty Balloons Market Key Players:

  1. SIS Medical
  2. Poba Medical
  3. Anchor Balloon
  4. Infinity Angioplasty Balloon
  5. Translumina Therapeutics
  6. Medtronic
  7. Johnson & Johnson Services, Inc.
  8. Abbott
  9. Terumo
  10. B. Braun
  11. Cook Medical
  12. Angiodynamics
  13. Merit Medical Systems
  14. Boston Scientific Corporation
  15. Koninklijke Philips N.V.
  16. Becton, Dickinson and Company
  17. BIOTRONIK
  18. B. Braun SE
  19. ENDOCOR GmbH & CO
  20. CTK Biotech, Inc.


Frequently Asked Questions

Rising incidences of cardiovascular diseases is the driver of the Angioplasty Balloons Market.

1.    Angioplasty Balloons Market: Research Methodology 
2.    Angioplasty Balloons Market: Executive Summary
3.    Angioplasty Balloons Market: Competitive Landscape
4.    Potential Areas for Investment

4.1. Stellar Competition Matrix
4.2. Competitive Landscape
4.3. Key Players Benchmarking
4.4. Market Structure
4.4.1.    Market Leaders 
4.4.2.    Market Followers
4.4.3.    Emerging Players

4.5. Consolidation of the Market
5.    Angioplasty Balloons Market Import Export Landscape
5.1. Import Trends
5.2. Export Trends
5.3. Regulatory Compliance
5.4. Major Export Destinations
5.5. Import-Export Disparities
6.    Angioplasty Balloons Market: Dynamics
6.1. Market Trends by Region
6.1.1.    North America
6.1.2.    Europe
6.1.3.    Asia Pacific
6.1.4.    Middle East and Africa
6.1.5.    South America

6.2. Market Drivers by Region
6.2.1.    North America
6.2.2.    Europe
6.2.3.    Asia Pacific
6.2.4.    Middle East and Africa
6.2.5.    South America

6.3. Market Restraints
6.4. Market Opportunities
6.5. Market Challenges
6.6. PORTER’s Five Forces Analysis
6.7. PESTLE Analysis
6.8. Strategies for New Entrants to Penetrate the Market
6.9. Regulatory Landscape by Region
6.9.1.    North America
6.9.2.    Europe
6.9.3.    Asia Pacific
6.9.4.    Middle East and Africa
6.9.5.    South America

7.    Angioplasty Balloons Market Size and Forecast by Segments (by Value Units)
7.1. Angioplasty Balloons Market Size and Forecast, by Type (2023-2030)
7.1.1.    Normal Balloons
7.1.2.    Scoring Balloons
7.1.3.    Drug-eluting Balloons
7.1.4.    Cutting Balloons

7.2. Angioplasty Balloons Market Size and Forecast, by Application (2023-2030)
7.2.1.     Peripheral
7.2.2.    Coronary

7.3. Angioplasty Balloons Market Size and Forecast, by End Use (2023-2030)
7.3.1.    Hospitals
7.3.2.    Ambulatory Surgical Centres
7.3.3.    Other End Users

7.4. Angioplasty Balloons Market Size and Forecast, by Region (2023-2030)
7.4.1.    North America
7.4.2.    Europe
7.4.3.    Asia Pacific
7.4.4.    Middle East and Africa
7.4.5.    South America

8.    North America Angioplasty Balloons Market Size and Forecast (by Value Units)
8.1. North America Angioplasty Balloons Market Size and Forecast, by Type (2023-2030)
8.1.1.    Normal Balloons
8.1.2.    Scoring Balloons
8.1.3.    Drug-eluting Balloons
8.1.4.    Cutting Balloons

8.2. Angioplasty Balloons Market Size and Forecast, by Application (2023-2030)
8.2.1.     Peripheral
8.2.2.    Coronary

8.3. Angioplasty Balloons Market Size and Forecast, by End Use (2023-2030)
8.3.1.    Hospitals
8.3.2.    Ambulatory Surgical Centres
8.3.3.    Other End Users

8.4. North America Angioplasty Balloons Market Size and Forecast, by Country (2023-2030)
8.4.1.    United States
8.4.2.    Canada
8.4.3.    Mexico

9.    Europe Angioplasty Balloons Market Size and Forecast (by Value Units)
9.1. Europe Angioplasty Balloons Market Size and Forecast, by Type (2023-2030)
9.1.1.    Normal Balloons
9.1.2.    Scoring Balloons
9.1.3.    Drug-eluting Balloons
9.1.4.    Cutting Balloons

9.2. Angioplasty Balloons Market Size and Forecast, by Application (2023-2030)
9.2.1.     Peripheral
9.2.2.    Coronary

9.3. Angioplasty Balloons Market Size and Forecast, by End Use (2023-2030)
9.3.1.    Hospitals
9.3.2.    Ambulatory Surgical Centres
9.3.3.    Other End Users

9.4. Europe Angioplasty Balloons Market Size and Forecast, by Country (2023-2030)
9.4.1.    UK
9.4.2.    France
9.4.3.    Germany
9.4.4.    Italy
9.4.5.    Spain
9.4.6.    Sweden
9.4.7.    Russia 
9.4.8.    Rest of Europe

10.    Asia Pacific Angioplasty Balloons Market Size and Forecast (by Value Units)
10.1. Asia Pacific Angioplasty Balloons Market Size and Forecast, by Type (2023-2030)
10.1.1.    Normal Balloons
10.1.2.    Scoring Balloons
10.1.3.    Drug-eluting Balloons
10.1.4.    Cutting Balloons

10.2. Angioplasty Balloons Market Size and Forecast, by Application (2023-2030)
10.2.1.     Peripheral
10.2.2.    Coronary

10.3. Angioplasty Balloons Market Size and Forecast, by End Use (2023-2030)
10.3.1.    Hospitals
10.3.2.    Ambulatory Surgical Centres
10.3.3.    Other End Users

10.4. Asia Pacific Angioplasty Balloons Market Size and Forecast, by Country (2023-2030)
10.4.1.    China
10.4.2.    S Korea
10.4.3.    Japan
10.4.4.    India
10.4.5.    Australia
10.4.6.    Indonesia 
10.4.7.    Malaysia
10.4.8.    Vietnam
10.4.9.    Taiwan
10.4.10.    Bangladesh
10.4.11.    Pakistan
10.4.12.    Rest of Asia Pacific

11.    Middle East and Africa Angioplasty Balloons Market Size and Forecast (by Value Units)
11.1. Middle East and Africa Angioplasty Balloons Market Size and Forecast, by Type (2023-2030)
11.1.1.    Normal Balloons
11.1.2.    Scoring Balloons
11.1.3.    Drug-eluting Balloons
11.1.4.    Cutting Balloons

11.2. Middle East and Africa Market Size and Forecast, by Application (2023-2030)
11.2.1.     Peripheral
11.2.2.    Coronary

11.3. Angioplasty Balloons Market Size and Forecast, by End Use (2023-2030)
11.3.1.    Hospitals
11.3.2.    Ambulatory Surgical Centres
11.3.3.    Other End Users

11.4. Middle East and Africa Angioplasty Balloons Market Size and Forecast, by Country (2023-2030)
11.4.1.    South Africa
11.4.2.    GCC
11.4.3.    Egypt
11.4.4.    Nigeria
11.4.5.    Rest of ME&A

12.    South America Angioplasty Balloons Market Size and Forecast (by Value Units)
12.1. South America Angioplasty Balloons Market Size and Forecast, by Type (2023-2030)
12.1.1.    Normal Balloons
12.1.2.    Scoring Balloons
12.1.3.    Drug-eluting Balloons
12.1.4.    Cutting Balloons

12.2. South America Market Size and Forecast, by Application (2023-2030)
12.2.1.     Peripheral
12.2.2.    Coronary

12.3. Angioplasty Balloons Market Size and Forecast, by End Use (2023-2030)
12.3.1.    Hospitals
12.3.2.    Ambulatory Surgical Centres
12.3.3.    Other End Users

12.4. South America Angioplasty Balloons Market Size and Forecast, by Country (2023-2030)
12.4.1.    Brazil
12.4.2.    Argentina
12.4.3.    Rest of South America

13.    Company Profile: Key players
13.1. Abbott
13.1.1.1.    Company Overview
13.1.1.2.    Financial Overview
13.1.1.3.    Business Portfolio
13.1.1.4.    SWOT Analysis
13.1.1.5.    Business Strategy 
13.1.1.6.    Recent Developments

13.2. SIS Medical
13.3. Poba Medical
13.4. Anchor Balloon
13.5. Infinity Angioplasty Balloon
13.6. Translumina Therapeutics
13.7. Medtronic
13.8. Johnson & Johnson Services, Inc.
13.9. Terumo
13.10. B. Braun
13.11. Cook Medical
13.12. Angiodynamics
13.13. Merit Medical Systems
13.14. Boston Scientific Corporation
13.15. Koninklijke Philips N.V.
13.16. Becton, Dickinson and Company
13.17. BIOTRONIK
13.18. B. Braun SE
13.19. ENDOCOR GmbH & CO
13.20. CTK Biotech, Inc.
14.    Key Findings
15.    Industry Recommendation

Enquiry Before Buy


Request Sample PDF